Every product has its life cycle, most of them not too terribly long. It seems to be a human reality that not too many people are good at taking a clean sheet of paper – a completely empty space – and conjuring up something entirely new; but once someone has done that, it is easy for others to see what has been conjured up and improve on it. So Chrysler creates the concept of the mini van and has a few years in the sun, but soon enough every other car maker takes the initial idea and makes mini vans that are better or cheaper. On the other hand, processes to continuously improve existing products, and processes to produce them have no practical limits. They also are much harder for competitors to discern and imitate. The whole world knows what product is being sold, but who knows what is happening in the bowels of the factories and engineering offices to make them?
For years - decades, in fact - this basic reality was Toyota's key to success. I can't recall a single time when the auto world or the consumers were wowed by one of Toyota's new products. Their products were never bad, of course. They were stylish enough and had enough new features so as to be competitive, but there were never screaming headlines from the car shows marveling at the breakthrough in car styling from Toyota. What they did was made a steady stream of cars that were 6's or 7's on the design scale and ran them through processes that were virtually 10's on the cost, quality and delivery scale. A Toyota may not have turned many heads when it passed by, but the price was right, and the quality and reliability were off the charts.
The business press and the politicians don't understand this because they don't don't know much about the processes it takes to make things. They know companies primarily as a set of products. The one with the coolest, most exciting products seems to them to be the best company. Wall Street probably doesn't understand either, but more important, it doesn't care. A fantastic new product can have a bottle rocket effect on profits even if it is produced via lousy processes, and Wall Street loves bottle rockets. During Chrysler's brief mini van run, profits soared and stock prices rose dramatically. The profits and stock prices soon returned to their dismal levels once the innovative product run was over because profits are a function of processes in the long haul – but no one on Wall Street cares about the long haul.
The pharmaceutical companies are another great example. They are all about innovative new drugs, and use patent protection to shield them from the consequences of lousy manufacturing processes. As a result, they lose the long term value from their products to generic manufacturers who thrive on good processes, and the big pharmas live and die (more often dying lately) with their product innovation.
This basic principle is at the heart of my criticism of Apple a few weeks back that generated the first out pouring of genuine hate mail I have received since I began writing on Evolving Excellence over six years ago. They were written by people who were passionate fans of Apple products, but not too well tuned into the so-so (at best) manufacturing and supply chain processes Apple has in place to deliver them. The Apple business model has been all about innovative products, but mediocre processes and, as a result is a business model that has been a series of spectacular bottle rockets but is not sustainable. It comes a no big surprise to me that Samsung just passed Apple in smart phone sales. Before long someone will surpass them in pad sales – it is inevitable. It is also why I give such short shrift to the economists and politicians who are all in on the innovation band wagon. By and large, they mean innovative products, not innovative processes, so they are urging an unsustainable business and economic model.
Of course, the best of all worlds is to do both – great products and great processes – but if a company is going to focus on one, making a line up of good products through great, innovative processes is the way to go, rather than to keep searching for the great product while paying little attention to processes. It is very much a 'tortoise and the hare' deal – slow and steady wins the race every time - even though there are times during the race when the hare might look fantastic.
Jeff says
Bill, you might be a little harsh on the pharm companies. Yes, they should spend more effort on manufacturing. Yes, the reliance on “block buster” new drugs may be an issue. However, (1) they operate in a regulatory environment where it can cost over $1 billion in R&D to get a single drug to market. They must recoup this investment in the life of the patent. (2) People’s lives are at stake with the development of every new drug. The stakes are high and so are the risks – people will die if they fail to develop a drug and if they release a drug with fatal side effects. I don’t know how a TPS driven company would have a culture capible of operating in such a high risk / high reward world…
Paul Todd says
This reminds me of a great quote attributed to Stanford professor James March: “Leadership involves plumbing as well as poetry.” So it is with manufacturing, that innovation and execution are two sides of the same coin.
Bill Waddell says
Jeff,
You may be right that I am too harsh, however, I have a hard time reconciling your assertion – a very valid assertion – that “the stakes are high and so are the risks” with their propensity to move manufacturing to Puerto Rico, and J&J/McNeil’s inability to maintain fundamental cleanliness in their plants. They may be attuned to the risks in product development, but they do not seem overly concerned with the risks of lousy manufacturing practices.
The proof of the pudding is in the eating. How is it that with a seven year head start in developing manufacturing processes for every new product, the phramas get their clocks cleaned by the generic manufaturers as soon as their drugs come out from under patent protection? One would think that with seven years to continuously improve and fine tune production they would be so good no one could touch them when it comes to manufacturing the drugs they develop.
David Hallsted says
This would explain Jerry Wright’s (past Western Division AME President) frustration with Silicon Valley. Jerry never understood why the Valley was not concern with manufacturing processes. And there is me, in the middle of Silicon Valley, wondering why processes are not important to my company. It is all about the latest product or the latest technology that will save the company. The innovation madness out strips any reason to look at what we are doing, instead we race off to the next WOW product and hope it continues our success leaving behind a trail of fire to be put out.
The only hope for the Valley is coming from software. It is called Agile, which to my surprise is Just-in-Time in software development. Agile is a process of programming just what code is needed within a quick cycle of testing to find out if it is working. I wish AME would partner with the various Agile groups around the nation. Perhaps then, the innovation companies in the Valley could see that their process is no different than any other process whether you are coding, or building widgets, or designing the next WOW product.
LITNE says
Was a candidate for a global lean leadership position with a very, very large multin-national pharma company a few years ago. Was “1st runner up” which means was not hired. Luckily, as it turns out. Their state reason for giving the position to the other candidate was that my philosophy of implementing lean initiatives was “too quick. Here at ‘Big Pharma-Co’ we pride ourselves on our slow, methodical approach to everything, including the lean transformation.” Yeesh, no wonder they can’t develop competetive processes if that is a common philosophy.
Marty Yuzwa says
Bill,
I actually liked your original Apple article, but after reading this article in businessweek, I actually am beginning to believe that Apple’s real innovation is in it’s supply chain and production – not it’s products. They may not be “lean”, but the article makes some very nice points. Would love to hear your comments after you read the article.
http://www.businessweek.com/magazine/apples-supplychain-secret-hoard-lasers-11032011.html